U.S., Oct. 21 -- ClinicalTrials.gov registry received information related to the study (NCT07883954) titled 'Development and Multi-Centre Validation of a Novel Non-Invasive Melanoma Molecular Diagnostic Test' on Oct. 06.
Brief Summary: Background and Study Aims:
Melanoma is the most dangerous form of skin cancer, and early detection is crucial for improving patient outcomes. Over 90% of suspected skin cancer lesions are not melanoma, leading to a significant proportion of patients undergoing invasive skin biopsies for non-relevant lesions (1). Mitra Bio has developed a novel, non-invasive skin-tape test that captures skin cells from pigmented lesions that are suspected of being melanoma and detects the presence of melanoma-specific methyl...